Shanxiang Zhang

Shanxiang Zhang

Auto-generated profile, based on publicly available information

Shanxiang Zhang

South China Normal University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
ZHZhihong Hu
Zhihong Hu
ZPZenggang Pan
Zenggang Pan
WCWeina Chen
Weina Chen
YSYang Shi
Yang Shi
WWWei Wang
Wei Wang
SHShimin Hu
Shimin Hu
Primary effusion lymphoma (PEL) is a rare type of large B-cell lymphoma associated with human herpesvirus 8 (HHV8) infection. Patients with PEL usually present with an effusion, but occasionally with an extracavitary mass. In this study, we reported a cohort of 70 patients with PEL: 67 men and 3 women with a median age of 46 years (range 26–91). Of these, 56 (80%) patients had human immunodeficiency virus (HIV) infection, eight were HIV-negative, and six had unknown HIV status. Nineteen (27%) patients had Kaposi sarcoma. Thirty-five (50%) patients presented with effusion only, 27 (39%) had an extracavitary mass or masses only, and eight (11%) had both effusion and extracavitary disease. The lymphoma cells showed plasmablastic, immunoblastic, or anaplastic morphology. All 70 (100%) cases were positive for HHV8. Compared with effusion-only PEL, patients with extracavitary-only PEL were younger (median age, 42 vs. 52 years, p = 0.001), more likely to be HIV-positive (88.9% vs. 68.6%, p = 0.06) and EBV-positive (76.9% vs. 51.9%, p = 0.06), and less often positive for CD45 (69.2% vs. 96.2%, p = 0.01), EMA (26.7% vs. 100%, p = 0.0005), and CD30 (60% vs. 81.5%, p = 0.09). Of 52 (50%) patients with clinical follow-up, 26 died after a median follow-up time of 40.0 months (range 0–96), and the median overall survival was 42.5 months. The median OS for patients with effusion-only and with extracavitary-only PEL were 30.0 and 37.9 months, respectively (p = 0.34), and patients with extracavitary-only PEL had a lower mortality rate at the time of last follow-up (35% vs. 61.5%, p = 0.07). The median OS for HIV-positive and HIV-negative patients were 42.5 and 6.8 months, respectively (p = 0.57), and they had a similar mortality rate of 50% at last follow-up. In conclusion, patients presenting with effusion-only versus extracavitary-only disease are associated with different clinicopathologic features. PEL is an aggressive lymphoma with a poor prognosis, regardless of extracavitary presentation or HIV status.

29 April 2022 in Photonics Research
Verified
Journal Article
Closed access
YLYujing Li
Yujing Li
SZShanxiang Zhang
Shanxiang Zhang
LWLinghua Wu
Linghua Wu
ZCZhongwen Cheng
Zhongwen Cheng
ZZZhang Zhenhui
Zhang Zhenhui
欢 覃欢 覃
欢 覃
Polarization optical imaging can be used to characterize anisotropy in biological tissue microstructures and has been demonstrated to be a powerful tool for clinical diagnosis. However, the approach is limited by an inability to image targets deeper than ∼ 1    mm due to strong optical scattering in biological tissues. As such, we propose a novel polarization microwave-induced thermoacoustic imaging (P-MTAI) technique to noninvasively detect variations in deep tissue by exploiting the thermoacoustic signals induced by four pulsed microwaves of varying polarization orientations. The proposed P-MTAI method overcomes the penetration limits of conventional polarization optical imaging and provides submillimeter resolution over depths of several centimeters. As part of the paper, the structural characteristics of tissues were quantified using a new parameter, the degree of microwave absorption anisotropy. P-MTAI was also applied to the noninvasive detection of morphological changes in cardiomyocytes as they transitioned from ordered to disordered states, providing a potential indication of myocardial infarction.

1 February 2017 in Annals of Diagnostic Pathology
Verified
Journal Article
Closed access
SZShanxiang Zhang
Shanxiang Zhang
JSJihong Sun
Jihong Sun
YFYanan Fang
Yanan Fang
MNMehdi Nassiri
Mehdi Nassiri
LLLanting Liu
Lanting Liu
GVGail H. Vance
Gail H. Vance

1 June 2020 in Cancer Genetics
Verified
Journal Article
Closed access
NZNives Zimmermann
Nives Zimmermann
MNMehdi Nassiri
Mehdi Nassiri
JZJiehao Zhou
Jiehao Zhou
AMAdam M. Miller
Adam M. Miller
SZShanxiang Zhang
Shanxiang Zhang

24 June 2019 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
SZShanxiang Zhang
Shanxiang Zhang
LWLin Wang
Lin Wang
LCLiang Cheng
Liang Cheng

1 August 2017 in Human Pathology
Verified
Journal Article
Closed access
SZShanxiang Zhang
Shanxiang Zhang
MBMichael G. Bayerl
Michael G. Bayerl